The genomic rearrangements leading to the fusion of the AR-regulated TMPRSS2 gene promoter and the N-terminally deleted ERG coding sequence represents the most common prostate cancer-specific driver gene alteration [60,76,77]. Here, ERG is linked to prostate carcinoma.